Arthur Kwok Leung Cheung

Chinese University of Hong Kong — China

Biochemistry, Genetics and Molecular Biology · Life Sciences

22h-index1.7kcitations62works2.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

RNA modifications and cancer(18), Cancer-related gene regulation(15), Cancer, Hypoxia, and Metabolism(8), Epigenetics and DNA Methylation(7), Microtubule and mitosis dynamics(7)

Publications62 total

Activation of Cgas-Sting Pathway By Hypomethylating Agent in <i>TP53</i> Mutated MDS/AML
Blood·2024· 2 cited
Supplementary Table 1 from Polo-like Kinase Inhibitor Ro5203280 Has Potent Antitumor Activity in Nasopharyngeal Carcinoma
2023Open Access
Supplementary Figure 4 from Polo-like Kinase Inhibitor Ro5203280 Has Potent Antitumor Activity in Nasopharyngeal Carcinoma
2023Open Access
Supplementary Figure 1 from Polo-like Kinase Inhibitor Ro5203280 Has Potent Antitumor Activity in Nasopharyngeal Carcinoma
2023Open Access
Supplementary Figure Legend from Polo-like Kinase Inhibitor Ro5203280 Has Potent Antitumor Activity in Nasopharyngeal Carcinoma
2023Open Access
Supplementary Figure 2 from Polo-like Kinase Inhibitor Ro5203280 Has Potent Antitumor Activity in Nasopharyngeal Carcinoma
2023Open Access
Data from Polo-like Kinase Inhibitor Ro5203280 Has Potent Antitumor Activity in Nasopharyngeal Carcinoma
2023Open Access
Supplementary Figure 3 from Polo-like Kinase Inhibitor Ro5203280 Has Potent Antitumor Activity in Nasopharyngeal Carcinoma
2023Open Access
Supplementary Figure Legend from Polo-like Kinase Inhibitor Ro5203280 Has Potent Antitumor Activity in Nasopharyngeal Carcinoma
2023Open Access
Supplementary Figure 1 from Polo-like Kinase Inhibitor Ro5203280 Has Potent Antitumor Activity in Nasopharyngeal Carcinoma
2023Open Access
Supplementary Table 1 from Polo-like Kinase Inhibitor Ro5203280 Has Potent Antitumor Activity in Nasopharyngeal Carcinoma
2023Open Access
Supplementary Figure 2 from Polo-like Kinase Inhibitor Ro5203280 Has Potent Antitumor Activity in Nasopharyngeal Carcinoma
2023Open Access
Supplementary Figure 4 from Polo-like Kinase Inhibitor Ro5203280 Has Potent Antitumor Activity in Nasopharyngeal Carcinoma
2023Open Access
Supplementary Figure 3 from Polo-like Kinase Inhibitor Ro5203280 Has Potent Antitumor Activity in Nasopharyngeal Carcinoma
2023Open Access
Data from Polo-like Kinase Inhibitor Ro5203280 Has Potent Antitumor Activity in Nasopharyngeal Carcinoma
2023Open Access
Supplementary Table 1 from Extracellular Protease &lt;i&gt;ADAMTS9&lt;/i&gt; Suppresses Esophageal and Nasopharyngeal Carcinoma Tumor Formation by Inhibiting Angiogenesis
2023Open Access
Data from Extracellular Protease &lt;i&gt;ADAMTS9&lt;/i&gt; Suppresses Esophageal and Nasopharyngeal Carcinoma Tumor Formation by Inhibiting Angiogenesis
2023Open Access
Supplementary Table 1 from Extracellular Protease &lt;i&gt;ADAMTS9&lt;/i&gt; Suppresses Esophageal and Nasopharyngeal Carcinoma Tumor Formation by Inhibiting Angiogenesis
2023Open Access
Data from Extracellular Protease &lt;i&gt;ADAMTS9&lt;/i&gt; Suppresses Esophageal and Nasopharyngeal Carcinoma Tumor Formation by Inhibiting Angiogenesis
2023Open Access
Functional characterization of a candidate tumor suppressor gene, <i>Mirror Image Polydactyly 1</i>, in nasopharyngeal carcinoma
International Journal of Cancer·2019· 9 citedOpen Access
page 1 of 4Next →

Frequent Co-authors

Maria Li Lung(46), Hong Lok Lung(29), Josephine Mun Yee Ko(24), Yue Cheng(20), Eric J. Stanbridge(15), Sai Wah Tsao(14), Wei Dai(11), Eugene R. Zabarovsky(11), Sai Wah Tsao(11), Joseph Chok Yan Ip(11), Jim Zhen Wu(9), Merrin Man‐Long Leong(7), Wai Tong Ng(7), Chun Chung Yau(7), Paulisally Hau Yi Lo(7), Fung Mei Kwong(7), Daniel Chua(7), Hong Zheng(6), Dora Lai‐Wan Kwong(6), Roger Kai Cheong Ngan(6)